NEW YORK, November 27, 2017 /PRNewswire/ --
In keeping with the commitment to dynamically provide members
with timely information WallStEquities.com has issued free tailored
Stock Review on PINC, MTBC, CERN, and EVH which is a click away at
http://www.wallstequities.com/registration. On Friday, benchmark US
indices were in bullish colors as the NASDAQ Composite closed the
trading session up 0.32%; the Dow Jones Industrial Average edged
0.14% higher; and the S&P 500 was up 0.21%. US markets made
broad based gains with all sectors finishing the day in green.
Pre-market today, WallStEquities.com reviews these four Healthcare
Information Services stocks: Premier Inc. (NASDAQ: PINC), Medical
Transcription Billing Corp. (NASDAQ: MTBC), Cerner Corp. (NASDAQ:
CERN), and Evolent Health Inc. (NYSE: EVH). With Wall St. Equities'
free research reports get an edge over stock markets, sign up now
at:
http://www.wallstequities.com/registration
Premier
Charlotte, North Carolina
headquartered Premier Inc.'s stock finished Friday's session 0.67%
lower at $28.31. A total volume of
734,539 shares was traded, which was above its three months average
volume of 601.53 thousand shares. The stock is trading below its
50-day moving average by 11.50%. Furthermore, shares of Premier,
which together with its subsidiaries, operates as a healthcare
improvement company in the US, have a Relative Strength Index (RSI)
of 33.91. Our free and thorough report on PINC awaits you at:
http://www.wallstequities.com/registration/?symbol=PINC
Medical Transcription Billing
Shares in Somerset, New Jersey
headquartered Medical Transcription Billing Corp. ended at
$2.61, down 2.97% from the last
trading session. The stock recorded a trading volume of 154,487
shares. The Company's shares have gained 82.52% over the previous
three months, 193.26% in the last twelve months, and 260.00% on an
YTD basis. The stock is trading above its 50-day and 200-day moving
averages by 2.40% and 65.23%, respectively. Moreover, shares of the
Company, which provides an integrated suite of Web-based solutions
and related business services to healthcare providers primarily in
the US, have an RSI of 50.86.
On November 14th, 2017,
research firm Chardan Capital Markets reiterated its 'Buy' rating
on the Company's stock with an increase of the target price from
$2.25 a share to $2.75 a share. MTBC complimentary research
coverage a few simple steps away at:
http://www.wallstequities.com/registration/?symbol=MTBC
Cerner
North Kansas City, Missouri
headquartered Cerner Corp.'s stock ended last Friday's session
0.77% higher at $70.57 with a total
trading volume of 2.05 shares. The Company's shares have advanced
39.71% in the last twelve months and 48.98% on an YTD basis. The
stock is trading above its 50-day and 200-day moving averages by
1.78% and 9.92%, respectively. Additionally, shares of Cerner,
which designs, develops, markets, installs, hosts, and supports
health care information technology, health care devices, hardware,
and content solutions for health care organizations and consumers
in the US and internationally, have an RSI of 64.51.
On November 02nd, 2017,
research firm RBC Capital Markets downgraded the Company's stock
rating from 'Top Pick' to 'Outperform' while revising its previous
target price from $84 a share to
$74 a share. Are you already
registered with Wall St. Equities? Do so now for free, and get the
report on CERN at:
http://www.wallstequities.com/registration/?symbol=CERN
Evolent Health
On Friday, shares in Arlington,
Virginia headquartered Evolent Health Inc. recorded a
trading volume of 756,445 shares. The stock finished the day 0.82%
lower at $12.05. The stock is trading
below its 50-day moving average by 21.42%. Furthermore, shares of
Evolent Health, which through its subsidiary, Evolent Health LLC,
provides healthcare delivery and payment solutions in the US, have
an RSI of 39.41. Aspiring Member, please take a moment to register
below for your free research report on EVH at:
http://www.wallstequities.com/registration/?symbol=EVH
--
Wall St. Equities:
Wall St. Equities (WSE) produces regular sponsored and
non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering equities listed on NYSE and NASDAQ
and micro-cap stocks. WSE has two distinct and independent
departments. One department produces non-sponsored analyst
certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE and NASDAQ and the
other produces sponsored content (in most cases not reviewed by a
registered analyst), which typically consists of compensated
investment newsletters, articles and reports covering listed stocks
and micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
WSE has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a
third-party research service company (the "Reviewer") represented
by a credentialed financial analyst [for further information on
analyst credentials, please email info@wallstequities.com.
Rohit Tuli, a CFA® charterholder
(the "Sponsor"), provides necessary guidance in preparing the
document templates. The Reviewer has reviewed and revised the
content, as necessary, based on publicly available information
which is believed to be reliable. Content is researched, written
and reviewed on a reasonable-effort basis. The Reviewer has not
performed any independent investigations or forensic audits to
validate the information herein. The Reviewer has only
independently reviewed the information provided by the Author
according to the procedures outlined by WSE. WSE is not entitled to
veto or interfere in the application of such procedures by the
third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content
outside of this document has no association with the Author or the
Reviewer in any way.
NO WARRANTY
WSE, the Author, and the Reviewer are not responsible for any
error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is
accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. WSE, the Author, and the
Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, WSE, the Author, and the Reviewer do not (1)
guarantee the accuracy, timeliness, completeness or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither WSE nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
https://wallstequities.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly.
If you're a company, we are
covering and wish to no longer feature on our coverage list contact
us via email and/or phone between 09:30 EDT
to 16:00 EDT from Monday to Friday at:
Email: info@wallstequities.com
Phone number: 21-32-044-483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore
228
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Wall St. Equities